{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:16:48Z","timestamp":1783019808883,"version":"3.54.6"},"reference-count":77,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1136\/bjophthalmol-2015-306700","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T02:31:33Z","timestamp":1431484293000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Persistent dilemmas in zoster eye disease"],"prefix":"10.1136","volume":"100","author":[{"given":"Elisabeth J","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"issue":"(2 Suppl)","key":"key-10.1136\/bjophthalmol-2015-306700-1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-3","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ophtha.2011.04.002","article-title":"Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years","volume":"118","author":"Ghaznawi","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"key-10.1136\/bjophthalmol-2015-306700-5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcv.2011.08.014","article-title":"Family history and herpes zoster risk in the era of shingles vaccination","volume":"52","author":"Hernandez","year":"2011","journal-title":"J Clin Virol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1532-5415.1971.tb01208.x","article-title":"Geriatric herpes zoster","volume":"19","author":"Rogers","year":"1971","journal-title":"J Am Geriatr Soc"},{"key":"key-10.1136\/bjophthalmol-2015-306700-7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"key":"key-10.1136\/bjophthalmol-2015-306700-8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/651078","article-title":"Increasing incidence of herpes zoster among veterans","volume":"50","author":"Rimland","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-9","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"key-10.1136\/bjophthalmol-2015-306700-10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","article-title":"Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK","volume":"82","author":"Breuer","year":"2014","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/bjd.12768","article-title":"Herpes zoster infection associated with acute coronary syndrome: a population-based retrospective cohort study","volume":"170","author":"Wang","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/jmv.23892","article-title":"Increased risk of cardiovascular events in patients with herpes zoster: a population-based study","volume":"86","author":"Wu","year":"2014","journal-title":"J Med Virol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ophtha.2012.09.007","article-title":"Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study","volume":"120","author":"Borkar","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Clinical practice. Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","article-title":"Herpes zoster in Germany: quantifying the burden of disease","volume":"11","author":"Ultsch","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2014predominance in the elderly and in women\u2014a register based study","volume":"13","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany","volume":"14","author":"Ultsch","year":"2013","journal-title":"Eur J Health Econ"},{"key":"key-10.1136\/bjophthalmol-2015-306700-20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/11317560-000000000-00000","article-title":"Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans","volume":"27","author":"White","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"key-10.1136\/bjophthalmol-2015-306700-21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archderm.1957.01550140037006","article-title":"The outcome of patients with herpes zoster","volume":"75","author":"De Moragas","year":"1957","journal-title":"AMA Arch Derm"},{"key":"key-10.1136\/bjophthalmol-2015-306700-22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","article-title":"Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice","volume":"153","author":"Bouhassira","year":"2012","journal-title":"Pain"},{"key":"key-10.1136\/bjophthalmol-2015-306700-23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PSY.0000000000000051","article-title":"Risk of depressive disorder among patients with herpes zoster: a nationwide population-based prospective study","volume":"76","author":"Chen","year":"2014","journal-title":"Psychosom Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-24","first-page":"37","article-title":"Treatment of acute herpetic neuralgia. A case report and review of the literature","volume":"73","author":"Hess","year":"1990","journal-title":"Minn Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-25","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmv.21254","article-title":"Clinical and psychosocial correlates of post-herpetic neuralgia","volume":"80","author":"Volpi","year":"2008","journal-title":"J Med Virol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3181d31e5c","article-title":"Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study","volume":"74","author":"Lin","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-27","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","article-title":"Increased risk of stroke after a herpes zoster attack: a population-based follow-up study","volume":"40","author":"Kang","year":"2009","journal-title":"Stroke"},{"key":"key-10.1136\/bjophthalmol-2015-306700-28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/cid\/ciu098","article-title":"Risk of stroke following herpes zoster: a self-controlled case-series study","volume":"58","author":"Langan","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-29","doi-asserted-by":"crossref","first-page":"e69156","DOI":"10.1371\/journal.pone.0069156","article-title":"The short- and long-term risk of stroke after herpes zoster\u2014a nationwide population-based cohort study","volume":"8","author":"Sreenivasan","year":"2013","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2015-306700-30","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"(RR-5)","key":"key-10.1136\/bjophthalmol-2015-306700-31","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key-10.1136\/bjophthalmol-2015-306700-32","unstructured":"Centers for Disease Control and Prevention. MMWR News Synopsis for 5 February 2015. http:\/\/www.cdc.gov\/media\/mmwrnews\/2015\/0205.html (accessed on 10 Mar 2015)."},{"key":"key-10.1136\/bjophthalmol-2015-306700-33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-34","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults >\/= 50 or years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"},{"key":"key-10.1136\/bjophthalmol-2015-306700-35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","article-title":"Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study","volume":"271","author":"Tseng","year":"2012","journal-title":"J Intern Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archophthalmol.2011.1881","article-title":"Uveitis exacerbation after varicella-zoster vaccination in an adult","volume":"130","author":"Sham","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archophthalmol.2010.142","article-title":"Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult","volume":"128","author":"Khalifa","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-38","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archophthalmol.2011.320","article-title":"Acute retinal necrosis after herpes zoster vaccination","volume":"129","author":"Charkoudian","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ajo.2012.11.022","article-title":"Increasing use of the vaccine against zoster through recommendation and administration by ophthalmologists at a city hospital","volume":"155","author":"Jung","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/ICO.0b013e318283453a","article-title":"Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination","volume":"32","author":"Elkin","year":"2013","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306700-43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/ICL.0000000000000041","article-title":"Improving adherence to national recommendations for zoster vaccination through simple interventions","volume":"40","author":"Elkin","year":"2014","journal-title":"Eye Contact Lens"},{"key":"key-10.1136\/bjophthalmol-2015-306700-44","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2015-306700-45","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.1136\/bjophthalmol-2015-306700-46","unstructured":"Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices Summary Report. 2014. http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-jun13.pdf (accessed 8 Jan 2015)."},{"key":"key-10.1136\/bjophthalmol-2015-306700-47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7547-8-7","article-title":"A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK","volume":"8","author":"Moore","year":"2010","journal-title":"Cost Eff Resour Alloc"},{"key":"key-10.1136\/bjophthalmol-2015-306700-48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40273-012-0020-7","article-title":"A systematic review of the cost effectiveness of herpes zoster vaccination","volume":"31","author":"Szucs","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"key-10.1136\/bjophthalmol-2015-306700-49","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-50","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-51","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.vaccine.2014.10.039","article-title":"Modeling the durability of ZOSTAVAX\u00ae vaccine efficacy in people \u226560 years of age","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"key":"key-10.1136\/bjophthalmol-2015-306700-52","article-title":"Safety, tolerability, and immunogenicity of a booster dose of zoster vaccine administered \u2265 10 years after a first dose compared with a first dose of zoster vaccine","author":"Levin","year":"2013"},{"key":"key-10.1136\/bjophthalmol-2015-306700-53","first-page":"88","article-title":"Herpes zoster recurrences more frequent than previously reported","volume-title":"Mayo Clin Proc","author":"Yawn","year":"2011"},{"key":"key-10.1136\/bjophthalmol-2015-306700-54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0161-6420(92)31849-4","article-title":"Oral acyclovir for herpes zoster ophthalmicus","volume":"99","author":"Hoang-Xuan","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/02713688709020090","article-title":"Observations on the natural history of herpes zoster ophthalmicus","volume":"6","author":"Cobo","year":"1987","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-306700-56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0924-8579(94)90024-8","article-title":"Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients","volume":"4","author":"Degreef","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.1136\/bjophthalmol-2015-306700-57","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archfami.9.9.863","article-title":"Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older","volume":"9","author":"Tyring","year":"2000","journal-title":"Arch Fam Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/ICO.0000000000000020","article-title":"Treatment of pseudodendrites in herpes zoster ophthalmicus with topical ganciclovir 0.15% gel","volume":"33","author":"Aggarwal","year":"2014","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306700-59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/ICO.0b013e31823cbe6a","article-title":"Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus","volume":"31","author":"Sy","year":"2012","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306700-60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/ICO.0000000000000129","article-title":"Clinical features of ocular herpetic infection in an Italian referral center","volume":"33","author":"Miserocchi","year":"2014","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306700-61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archopht.1995.01100110041023","article-title":"Delayed herpes zoster pseudodendrites. Polymerase chain reaction detection of viral DNA and a role for antiviral therapy","volume":"113","author":"Pavan-Langston","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajo.2009.08.030","article-title":"Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus","volume":"149","author":"Hu","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-63","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-306700-64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archophthalmol.2011.379","article-title":"The role of antiviral therapy after the resolution of acute herpes simplex keratitis or acute herpes zoster ophthalmicus","volume":"130","author":"Baratz","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/14796708.4.1.103","article-title":"Clinical and molecular aspects of varicella zoster virus infection","volume":"4","author":"Gilden","year":"2009","journal-title":"Future Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13550289509111018","article-title":"Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia","volume":"1","author":"Mahalingam","year":"1995","journal-title":"J Neurovirol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-67","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/01.wnl.0000258549.13334.16","article-title":"The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy","volume":"68","author":"Nagel","year":"2007","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/WCO.0000000000000092","article-title":"Neurological complications of varicella zoster virus reactivation","volume":"27","author":"Nagel","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10384-014-0340-6","article-title":"Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus","volume":"58","author":"Takase","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-70","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/infdis\/jir425","article-title":"Persistence of varicella zoster virus DNA in saliva after herpes zoster","volume":"204","author":"Nagel","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jmv.23834","article-title":"Search for varicella zoster virus DNA in saliva of healthy individuals aged 20\u201359 years","volume":"86","author":"Birlea","year":"2014","journal-title":"J Med Virol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-72","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jns.2013.09.034","article-title":"Varicella zoster virus in the temporal artery of a patient with giant cell arteritis","volume":"335","author":"Nagel","year":"2013","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/bjophthalmol-2015-306700-73","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e318294b477","article-title":"Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis","volume":"80","author":"Nagel","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-74","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","author":"Gilden","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-306700-75","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/ciu099","article-title":"Editorial commentary: varicella zoster virus infection: generally benign in kids, bad in grown-ups","volume":"58","author":"Nagel","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306700-76","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","article-title":"Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976\u20132007: the effect of oral antiviral prophylaxis","volume":"128","author":"Young","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306700-77","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.066","article-title":"Antiviral therapy of varicella-zoster virus infections","volume-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Gnann","year":"2007"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:50:13Z","timestamp":1601110213000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-306700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/bjophthalmol-2015-306700"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306700","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}